Rockwood Wealth Management’s Insmed INSM Stock Holding History

Rockwood Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-42,001	Closed	-$886K	–	73
2023 Q2	$886K	Buy	+42,001	New	+$797K	0.15%	31
2023 Q1	–	Sell	-42,000	Closed	-$839K	–	71
2022 Q4	$839K	Hold	42,000	–	–	0.2%	29
2022 Q3	$905K	Hold	42,000	–	–	0.29%	24
2022 Q2	$828K	Hold	42,000	–	–	0.39%	21
2022 Q1	$987K	Hold	42,000	–	–	0.47%	15
2021 Q4	$1.14M	Buy	+42,000	New	+$1.2M	0.51%	20

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Rockwood Wealth Management's INSM Position: Q3 2023 in Review

Rockwood Wealth Management sold out of Insmed (INSM) in Q3 2023, closing a stake of 42,001 shares — an estimated $886K sold.

Rockwood Wealth Management first reported a position in INSM in Q4 2021 and held it in 6 quarters. The position peaked at $1.14M in Q4 2021. 252 funds tracked by Wall St. Rank hold INSM as of Q3 2023.

Rockwood Wealth Management reported no remaining Insmed position as of Q3 2023 after selling out during the quarter.
Rockwood Wealth Management sold 42,001 Insmed shares in Q3 2023, an estimated $886K.
Rockwood Wealth Management first reported a position in Insmed in Q4 2021 and held it in 6 quarters.
Rockwood Wealth Management's Insmed position peaked at $1.14M in Q4 2021.
252 funds tracked by Wall St. Rank held Insmed as of Q3 2023.

Based on Rockwood Wealth Management's 13F filing for Q3 2023, filed 10 Oct 2023.